News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ThromboGenics NV (TBGNF)' Founder Prof Desire Collen Retiring As Chairman



12/9/2013 6:51:51 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

LEUVEN, Belgium, December 6, 2013 /PRNewswire via COMTEX/ -- Dr Staf Van Reet appointed as new Chairman of the Board

ThromboGenics NV (euronext brussels:THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces today that Prof Désiré Collen has decided to retire as Chairman and board member. Dr Staf Van Reet, currently a member of the ThromboGenics Board and a seasoned biopharma veteran, has been appointed Chairman of ThromboGenics.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES